HF3652 • 2026

Cost-sharing for epilepsy-related prescription drugs and medical supplies limited.

Healthcare

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor: Greene, Bierman, Klevorn, Howard, Falconer, Kozlowski, Virnig, Curran
Last action: 2026-04-27
Official status: Author added Curran
Effective date: Not listed

Plain English Breakdown

Using official source text because the generated explanation was unavailable or could not be confirmed against the official bill text.

Cost-sharing for epilepsy-related prescription drugs and medical supplies limited.

What This Bill Does

Cost-sharing for epilepsy-related prescription drugs and medical supplies limited.

Limits and Unknowns

This entry is temporarily using official source text because the generated explanation could not be confirmed against the official bill text during the last sync.

Bill History

2026-04-27 House
Author added Curran
2026-04-23 House
Authors added Kozlowski and Virnig
2026-03-18 House
Author added Falconer
2026-02-25 House
Author added Howard
2026-02-23 House
Introduction and first reading, referred to Commerce Finance and Policy

Official Summary Text

Cost-sharing for epilepsy-related prescription drugs and medical supplies limited.

Current Bill Text

Read the full stored bill text

A bill for an act

relating to health insurance; limiting cost-sharing for epilepsy-related prescription

drugs and medical supplies; amending Minnesota Statutes 2024, section 62Q.481,

subdivision 2.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF MINNESOTA:

Section 1.

Minnesota Statutes 2024, section 62Q.481, subdivision 2, is amended to read:

Subd. 2.

Definitions.

(a) For purposes of this section, the following definitions apply.

(b) "Chronic disease" means diabetes, asthma,
new text begin
epilepsy,
new text end
and allergies requiring the use

of epinephrine auto-injectors.

(c) "Cost-sharing" means co-payments and coinsurance.

(d) "Related medical supplies" means syringes, insulin pens, insulin pumps, test strips,

glucometers, continuous glucose monitors, epinephrine auto-injectors, asthma inhalers, and

other medical supply items necessary to effectively and appropriately treat a chronic disease

or administer a prescription drug prescribed to treat a chronic disease.

new text begin

EFFECTIVE DATE.

new text end

new text begin

This section is effective January 1, 2027, and applies to health

plans offered, issued, or renewed on or after that date.

new text end